Mangione charged with murder as 'manifesto' leaks online

A handwritten document by Luigi Mangione, the 26-year old man suspected of murdering UnitedHealthcare CEO Brian Thompson has been released. In the three-page letter—some of which is illegible—Mangione indirectly confessed to the crime and apologized for “any strife of traumas" resulting from his actions

The manifesto was first mentioned by police who arrested Mangione at a McDonald’s in Pennsylvania on Monday. Several fakes have been shared on social media; however, authorities have confirmed the version released by independent journalist Ken Klippenstein on his Subtack is legitimate.

Writing in what Mangione himself describes as a “spiral notebook,” he speaks directly to law enforcement saying “I do respect what you do for our country” and confirms he “wasn’t working with anyone,” likely referring to shooting and killing Thompson. 

“A reminder: the US has the #1 most expensive healthcare system in the world, yet we rank roughly #42 in life expectancy,” Mangione wrote. 

“United is the [indecipherable] largest company in the US by market cap, behind only Apple, Google, Walmart. It has grown and grown, but [h]as our life expectancy?,” he added

Along with the document, Mangione was found with what police referred to as a “ghost gun” that matches the caliber used to shoot Thompson. He also had multiple fake IDs, one of which he gave to police when confronted at the McDonald’s, law enforcement said. Mangione was subsequently charged in Pennsylvania for possession of fake IDs and the illegal gun. 

He has also been officially indicted for murder in New York. 

Mangione was arraigned in Pennsylvania court on Tuesday, where the specifics of his extradition will be decided. If convicted, he faces a life sentence. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.